Skip to content

Source filing unavailable

Q3 2024 · —
Revenue$2.54Mno prior Q3 2023 on file+30.2% vs Q2 2024
Net Income-$9.37Mno prior Q3 2023 on fileN/M vs Q2 2024
EPS Diluted$0.38no prior Q3 2023 on file+35.7% vs Q2 2024
Gross Profit$1,788,000—
Operating Income-$8,998,000—
Operating Cash Flowderived-$6,826,000—
Margins · derived
Gross margin70.3%
Operating margin-354.0%
Net margin-368.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q3 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Profound Medical Corp. · CIK 1628808 · Engraved from SEC EDGAR